{"transactions":[{"id":4615913,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":19812,"kind":"person","name":"Robertson Stephen P.","position":1,"cik":"0001837798","reported_name":"Robertson Stephen P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-09-11T20:26:04.000Z","date":"2026-09-10","kind":"sale","planned":false,"acquired":false,"shares":11939,"price":15.95,"value":190427.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of Performance Stock Units (PSUs) related to the February 28, 2025 performance award."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.95 to $15.96, inclusive. The reporting person undertakes to provide to\nthe Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange."}],"balance_after":588848,"source":{"system":"sec-edgar","filing":"0001600620-26-000068","document":"wk-form4_1789158362.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1837798/000160062026000068/wk-form4_1789158362.xml","form_type":"4"}},{"id":675843,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":19812,"kind":"person","name":"Robertson Stephen P.","position":1,"cik":"0001837798","reported_name":"Robertson Stephen P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-08-26T01:29:28.000Z","date":"2026-08-21","kind":"sale","planned":false,"acquired":false,"shares":20975,"price":16.97,"value":355945.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of Performance Stock Units (PSUs) related to the February 28, 2025 performance award."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.96 to $17.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 360 common shares that were acquired on May 29, 2026 by the reporting person pursuant to the Issuer's 2021 Employee Share Purchase Plan."}],"balance_after":600787,"source":{"system":"sec-edgar","filing":"0001837798-26-000013","document":"wk-form4_1787707766.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000183779826000013/wk-form4_1787707766.xml","form_type":"4"}},{"id":769597,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":19812,"kind":"person","name":"Robertson Stephen P.","position":1,"cik":"0001837798","reported_name":"Robertson Stephen P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-05-20T21:05:22.000Z","date":"2026-05-18","kind":"grant","planned":false,"acquired":true,"shares":115541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each performance stock unit (\"PSU\") represents a contingent right to receive one common share of the Issuer. 115,541 PSUs vest in two tranches at the three and five year anniversary date of grant if the Issuer's common shares achieve target prices that represent significant increases from the share price on date of grant before the respective vesting date."}],"balance_after":621402,"source":{"system":"sec-edgar","filing":"0001837798-26-000005","document":"wk-form4_1779311116.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000183779826000005/wk-form4_1779311116.xml","form_type":"4"}},{"id":865235,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":19812,"kind":"person","name":"Robertson Stephen P.","position":1,"cik":"0001837798","reported_name":"Robertson Stephen P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-03T21:12:57.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":98813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter."}],"balance_after":98813,"derivative":{"exercise_price":13.97,"expiration_date":"2036-02-27","underlying":"Common Stock","underlying_shares":98813},"source":{"system":"sec-edgar","filing":"0001600620-26-000019","document":"wk-form4_1772572374.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062026000019/wk-form4_1772572374.xml","form_type":"4"}},{"id":865234,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":19812,"kind":"person","name":"Robertson Stephen P.","position":1,"cik":"0001837798","reported_name":"Robertson Stephen P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2026-03-03T21:12:57.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":36525,"price":14.21,"value":519020.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units."}],"balance_after":505861,"source":{"system":"sec-edgar","filing":"0001600620-26-000019","document":"wk-form4_1772572374.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062026000019/wk-form4_1772572374.xml","form_type":"4"}},{"id":865233,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":19812,"kind":"person","name":"Robertson Stephen P.","position":1,"cik":"0001837798","reported_name":"Robertson Stephen P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2026-03-03T21:12:57.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":59090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each performance right represents a contingent right to receive one common share of the Issuer. The performance rights vest in four tranches upon the Issuer's common shares achieving four\nprogressively higher target prices, with respective one year retention periods per tranche achievement."}],"balance_after":542386,"source":{"system":"sec-edgar","filing":"0001600620-26-000019","document":"wk-form4_1772572374.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062026000019/wk-form4_1772572374.xml","form_type":"4"}},{"id":887484,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":19812,"kind":"person","name":"Robertson Stephen P.","position":1,"cik":"0001837798","reported_name":"Robertson Stephen P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2026-02-23T21:04:33.000Z","date":"2026-02-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":34638,"price":14.4,"value":498787.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units."}],"balance_after":483296,"source":{"system":"sec-edgar","filing":"0001837798-26-000002","document":"wk-form4_1771880670.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000183779826000002/wk-form4_1771880670.xml","form_type":"4"}},{"id":950028,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":19812,"kind":"person","name":"Robertson Stephen P.","position":1,"cik":"0001837798","reported_name":"Robertson Stephen P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2026-01-05T21:13:30.000Z","date":"2026-01-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":40385,"price":15.95,"value":644140.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy tax withholding obligations upon the vesting of performance awards."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes common shares acquired by the reporting person pursuant to the Issuer's 2021 Employee Share Purchase Plan as follows: 531 common shares were acquired on May 30, 2025 and 354\ncommon shares were acquired on November 28, 2025."}],"balance_after":517934,"source":{"system":"sec-edgar","filing":"0001600620-26-000005","document":"wk-form4_1767647607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062026000005/wk-form4_1767647607.xml","form_type":"4"}},{"id":950027,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":19812,"kind":"person","name":"Robertson Stephen P.","position":1,"cik":"0001837798","reported_name":"Robertson Stephen P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2026-01-05T21:13:30.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":48558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares earned upon certification of performance for a performance award payable solely in common shares of the Issuer that vest in two (2) equal annual installments on December 31, 2025 and December 31, 2026."}],"balance_after":557434,"source":{"system":"sec-edgar","filing":"0001600620-26-000005","document":"wk-form4_1767647607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062026000005/wk-form4_1767647607.xml","form_type":"4"}},{"id":1226422,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":19812,"kind":"person","name":"Robertson Stephen P.","position":1,"cik":"0001837798","reported_name":"Robertson Stephen P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-03-05T01:57:21.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":128438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter."}],"balance_after":128438,"derivative":{"exercise_price":7.55,"expiration_date":"2035-02-28","underlying":"Common Stock","underlying_shares":128438},"source":{"system":"sec-edgar","filing":"0001600620-25-000019","document":"wk-form4_1741139835.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062025000019/wk-form4_1741139835.xml","form_type":"4"}},{"id":1226421,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":19812,"kind":"person","name":"Robertson Stephen P.","position":1,"cik":"0001837798","reported_name":"Robertson Stephen P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2025-03-05T01:57:21.000Z","date":"2025-03-04","kind":"sale","planned":false,"acquired":false,"shares":57607,"price":7.92,"value":456247.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs related to the March 2, 2022 and March 2, 2023 grants."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.76 to $8.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":509276,"source":{"system":"sec-edgar","filing":"0001600620-25-000019","document":"wk-form4_1741139835.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062025000019/wk-form4_1741139835.xml","form_type":"4"}},{"id":1226420,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":19812,"kind":"person","name":"Robertson Stephen P.","position":1,"cik":"0001837798","reported_name":"Robertson Stephen P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2025-03-05T01:57:21.000Z","date":"2025-03-03","kind":"sale","planned":false,"acquired":false,"shares":64872,"price":8,"value":518976.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) related to the February 20, 2024 grant and March 2, 2023 performance\naward."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.79 to $8.13, inclusive. The reporting person undertakes to provide to the\nIssuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":566883,"source":{"system":"sec-edgar","filing":"0001600620-25-000019","document":"wk-form4_1741139835.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062025000019/wk-form4_1741139835.xml","form_type":"4"}},{"id":1226419,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":19812,"kind":"person","name":"Robertson Stephen P.","position":1,"cik":"0001837798","reported_name":"Robertson Stephen P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2025-03-05T01:57:21.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":102406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents grant of performance award payable solely in common shares of the Issuer that vest in two (2) equal annual installments on December 31, 2024 and December 31, 2025."}],"balance_after":631755,"source":{"system":"sec-edgar","filing":"0001600620-25-000019","document":"wk-form4_1741139835.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062025000019/wk-form4_1741139835.xml","form_type":"4"}},{"id":1226418,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":19812,"kind":"person","name":"Robertson Stephen P.","position":1,"cik":"0001837798","reported_name":"Robertson Stephen P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2025-03-05T01:57:21.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":84106,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each performance right represents a contingent right to receive one common share of the Issuer. The performance rights vest in four tranches upon the Issuer's common shares achieving four\nprogressively higher target prices, with respective one year retention periods per tranche achievement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes common shares acquired by the reporting person pursuant to the Issuer's 2021 Employee Share Purchase Plan as follows: 513 common shares were acquired on May 31, 2024 and 506 common shares were acquired on November 29, 2024."}],"balance_after":529349,"source":{"system":"sec-edgar","filing":"0001600620-25-000019","document":"wk-form4_1741139835.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062025000019/wk-form4_1741139835.xml","form_type":"4"}},{"id":1588557,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":19812,"kind":"person","name":"Robertson Stephen P.","position":1,"cik":"0001837798","reported_name":"Robertson Stephen P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2024-03-07T21:41:59.000Z","date":"2024-03-06","kind":"sale","planned":false,"acquired":false,"shares":57745,"price":5.6,"value":323372.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units related to the March 2, 2022 and March 2, 2023 grants."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.475 to $5.755, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":443824,"source":{"system":"sec-edgar","filing":"0001600620-24-000034","document":"wk-form4_1709847708.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062024000034/wk-form4_1709847708.xml","form_type":"4"}},{"id":1624611,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":19812,"kind":"person","name":"Robertson Stephen P.","position":1,"cik":"0001837798","reported_name":"Robertson Stephen P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2024-02-22T21:29:31.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":194230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of Restricted Stock Units (RSUs) payable solely in common stock of the Issuer that vest in three (3) equal annual installments on the first, second and third anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock acquired by the reporting person pursuant to the Issuer's 2021 Employee Share Purchase Plan as follows: 2,500 shares of common stock were acquired on May 31, 2023 and 1,717 shares of common stock were acquired on November 30, 2023."}],"balance_after":501569,"source":{"system":"sec-edgar","filing":"0001600620-24-000019","document":"wk-form4_1708637344.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062024000019/wk-form4_1708637344.xml","form_type":"4"}},{"id":1624609,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":19812,"kind":"person","name":"Robertson Stephen P.","position":1,"cik":"0001837798","reported_name":"Robertson Stephen P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2024-02-22T21:19:43.000Z","date":"2023-03-02","kind":"sale","planned":false,"acquired":false,"shares":19644,"price":8.78,"value":172474.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":303122,"source":{"system":"sec-edgar","filing":"0001600620-24-000015","document":"wk-form4a_1708636769.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062024000015/wk-form4a_1708636769.xml","form_type":"4/A","original_submission_date":"2023-03-06"}},{"id":1968229,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":19812,"kind":"person","name":"Robertson Stephen P.","position":1,"cik":"0001837798","reported_name":"Robertson Stephen P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2023-03-06T21:29:06.000Z","date":"2023-03-02","kind":"sale","acquired":false,"shares":19402,"price":8.94,"value":173453.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":303364,"source":{"system":"sec-edgar","filing":"0001628280-23-006530","document":"wf-form4_167813813532555.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828023006530/wf-form4_167813813532555.xml","form_type":"4"}},{"id":1968228,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":19812,"kind":"person","name":"Robertson Stephen P.","position":1,"cik":"0001837798","reported_name":"Robertson Stephen P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2023-03-06T21:29:06.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":204810,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of Restricted Stock Units (RSUs) payable solely in common stock of the Issuer that vest in three (3) equal annual installments on the first, second and third anniversary of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares of common stock acquired by the reporting person pursuant to the Issuer's 2021 Employee Share Purchase Plan as follows: 2,016 shares of common stock were acquired on May 31, 2022 and 178 shares of common stock were acquired on November 30, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 includes the 204,810 newly awarded RSUs, 104,080 RSUs previously reported in Table II, which vests in three (3) equal annual installments beginning March 2, 2022 (Prior RSUs), and 11,682 shares of common stock.  On March 2, 2023, 34,693 of Prior RSUs vested and 69,387 of Prior RSUs remained unvested."}],"balance_after":322766,"source":{"system":"sec-edgar","filing":"0001628280-23-006530","document":"wf-form4_167813813532555.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828023006530/wf-form4_167813813532555.xml","form_type":"4"}},{"id":2349662,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":19812,"kind":"person","name":"Robertson Stephen P.","position":1,"cik":"0001837798","reported_name":"Robertson Stephen P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-04T21:11:08.000Z","date":"2022-03-02","kind":"grant","acquired":true,"shares":178063,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter."}],"balance_after":178063,"derivative":{"exercise_price":12.01,"expiration_date":"2032-03-02","underlying":"Common Stock","underlying_shares":178063},"source":{"system":"sec-edgar","filing":"0001628280-22-005121","document":"wf-form4_164642825231972.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828022005121/wf-form4_164642825231972.xml","form_type":"4"}},{"id":2349661,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":19812,"kind":"person","name":"Robertson Stephen P.","position":1,"cik":"0001837798","reported_name":"Robertson Stephen P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Restricted Stock Unit","published_at":"2022-03-04T21:11:08.000Z","date":"2022-03-02","kind":"grant","acquired":true,"shares":104080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in three (3) equal annual installments beginning March 2, 2022, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in three (3) equal annual installments beginning March 2, 2022, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in three (3) equal annual installments beginning March 2, 2022, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date."}],"balance_after":104080,"derivative":{"underlying":"Common Shares","underlying_shares":104080},"source":{"system":"sec-edgar","filing":"0001628280-22-005121","document":"wf-form4_164642825231972.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828022005121/wf-form4_164642825231972.xml","form_type":"4"}},{"id":2349660,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":19812,"kind":"person","name":"Robertson Stephen P.","position":1,"cik":"0001837798","reported_name":"Robertson Stephen P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-03-04T21:11:08.000Z","date":"2022-03-02","kind":"grant","acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 18, 2021, the Reporting Person was granted stock based performance awards (\"Performance Awards\") which vests when specific performance metrics are met based on the results for the year ended December 31, 2021. It was determined that as of March 2, 2022, the Reporting Person partially met the performance criteria and received shares of common stock for no consideration."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 462 shares acquired by the Reporting Person under the Issuer's 2021 Employee Share Purchase Plan on December 1, 2021."}],"balance_after":11682,"source":{"system":"sec-edgar","filing":"0001628280-22-005121","document":"wf-form4_164642825231972.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828022005121/wf-form4_164642825231972.xml","form_type":"4"}},{"id":2889956,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":19812,"kind":"person","name":"Robertson Stephen P.","position":1,"cik":"0001837798","reported_name":"Robertson Stephen P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2021-01-29T17:24:16.000Z","date":"2021-01-28","kind":"purchase","acquired":true,"shares":900,"price":16.14,"value":14526.0,"ownership":{"direct":true},"balance_after":2720,"source":{"system":"sec-edgar","filing":"0001628280-21-001096","document":"wf-form4_161194104312841.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828021001096/wf-form4_161194104312841.xml","form_type":"4"}}]}